- Home
- Publications
- Publication Search
- Publication Details
Title
The Prognostic 97 Chemoresponse Gene Signature in Ovarian Cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-08-22
DOI
10.1038/s41598-017-08766-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High expression of orphan nuclear receptor NR4A1 in a subset of ovarian tumors with worse outcome
- (2016) Evan Delgado et al. GYNECOLOGIC ONCOLOGY
- An 8-gene signature for prediction of prognosis and chemoresponse in non-small cell lung cancer
- (2016) Muhammad Shahid et al. Oncotarget
- Prognostic value and their clinical implication of 89-gene signature in glioma
- (2016) Muhammad Shahid et al. Oncotarget
- A VEGF-dependent gene signature enriched in mesenchymal ovarian cancer predicts patient prognosis
- (2016) Xia Yin et al. Scientific Reports
- Prediction of resistance to chemotherapy in ovarian cancer: a systematic review
- (2015) Katherine L Lloyd et al. BMC CANCER
- A novel serum microRNA panel to discriminate benign from malignant ovarian disease
- (2015) Ream Langhe et al. CANCER LETTERS
- Creation of a Human Secretome: A Novel Composite Library of Human Secreted Proteins: Validation Using Ovarian Cancer Gene Expression Data and a Virtual Secretome Array
- (2015) V. Vathipadiekal et al. CLINICAL CANCER RESEARCH
- A Systems Oncology Approach Identifies NT5E as a Key Metabolic Regulator in Tumor Cells and Modulator of Platinum Sensitivity
- (2015) Ekaterina Nevedomskaya et al. JOURNAL OF PROTEOME RESEARCH
- A 10-gene expression signature of Notch pathway predicts recurrence in ovarian carcinoma
- (2015) FANG CHEN et al. Oncology Letters
- CRC-113 gene expression signature for predicting prognosis in patients with colorectal cancer
- (2015) Minh Nam Nguyen et al. Oncotarget
- Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer
- (2015) Kim Moran-Jones et al. Oncotarget
- Prognostic value of a 92-probe signature in breast cancer
- (2015) Salima Akter et al. Oncotarget
- Specific TP53 Mutants Overrepresented in Ovarian Cancer Impact CNV, TP53 Activity, Responses to Nutlin-3a, and Cell Survival
- (2015) Lisa K. Mullany et al. NEOPLASIA
- A chemoresponse assay for prediction of platinum resistance in primary ovarian cancer
- (2014) Thomas C. Krivak et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Overview of a chemoresponse assay in ovarian cancer
- (2014) E. C. Grendys et al. Clinical & Translational Oncology
- Comparative Meta-analysis of Prognostic Gene Signatures for Late-Stage Ovarian Cancer
- (2014) Levi Waldron et al. JNCI-Journal of the National Cancer Institute
- CYR61 overexpression associated with the development and poor prognosis of ovarian carcinoma
- (2014) Huimin Shen et al. MEDICAL ONCOLOGY
- The Role of MicroRNAs in Ovarian Cancer
- (2014) Yasuto Kinose et al. Biomed Research International
- Gene Expression Analysis in Ovarian Cancer – Faults and Hints from DNA Microarray Study
- (2014) Katarzyna Marta Lisowska et al. Frontiers in Oncology
- A Collagen-Remodeling Gene Signature Regulated by TGF-β Signaling Is Associated with Metastasis and Poor Survival in Serous Ovarian Cancer
- (2013) Dong-Joo Cheon et al. CLINICAL CANCER RESEARCH
- Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer
- (2013) Tuan Zea Tan et al. EMBO Molecular Medicine
- Histopathology predicts clinical outcome in advanced epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and debulking surgery
- (2013) Miho Muraji et al. GYNECOLOGIC ONCOLOGY
- Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: A Gynecologic Oncology Group study
- (2013) Lisa M. Landrum et al. GYNECOLOGIC ONCOLOGY
- Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: Safety and effectiveness
- (2013) Vanessa da Costa Miranda et al. GYNECOLOGIC ONCOLOGY
- Validating the impact of a molecular subtype in ovarian cancer on outcomes: A study of the OVCAD Consortium
- (2012) Dietmar Pils et al. CANCER SCIENCE
- Mdm2 antagonists induce apoptosis and synergize with cisplatin overcoming chemoresistance inTP53wild-type ovarian cancer cells
- (2012) Roser Mir et al. INTERNATIONAL JOURNAL OF CANCER
- Multi-Gene Expression Predictors of Single Drug Responses to Adjuvant Chemotherapy in Ovarian Carcinoma: Predicting Platinum Resistance
- (2012) J. Stuart Ferriss et al. PLoS One
- Human cancer cells express Slug-based epithelial-mesenchymal transition gene expression signature obtained in vivo
- (2011) Dimitris Anastassiou et al. BMC CANCER
- Expression signatures of TP53 mutations in serous ovarian cancers
- (2010) Marcus Q Bernardini et al. BMC CANCER
- Gene Expression Profiles as Prognostic Markers in Women With Ovarian Cancer
- (2010) Kirsten M. Jochumsen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Gene Expression Profile ofBRCAness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer
- (2010) Panagiotis A. Konstantinopoulos et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
- (2009) Andreas du Bois et al. CANCER
- A prognostic gene expression index in ovarian cancer-validation across different independent data sets
- (2009) Carsten Denkert et al. JOURNAL OF PATHOLOGY
- C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma
- (2008) S Mahner et al. BRITISH JOURNAL OF CANCER
- A Gene Signature Predicting for Survival in Suboptimally Debulked Patients with Ovarian Cancer
- (2008) T. Bonome et al. CANCER RESEARCH
- New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact
- (2008) Keren Levanon et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started